ACTR-03. A FEASIBILITY TRIAL OF THE MODIFIED ATKINS DIET AND BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA

BACKGROUND: We report results of a feasibility trial of the modified Atkins diet (MAD), a form of ketogenic diet (KD), combined with bevacizumab (Bev) for recurrent GBM. The rationale for a KD to treat GBM includes the reduction of glucose availability to this highly glycolytic tumor, reduction of a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Rogers, Lisa, Rolfe, Sarah, Devine, Karen, Peereboom, David, Palcsik, Michelle, Hamza, Mohamed, Riehl, Ann, Marsey, Marge, Berger, Nathan A, Gibbons, Joseph, Barnholtz-Sloan, Jill, Sloan, Andrew, Tatsuoka, Curt
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2018
Konular:
Abstracts
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216153/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.040
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller